Watch CNBC's full interview with Moderna CEO Stephane Bancel

Moderna CEO Stephane Bancel sits down with CNBC's Meg Tirrell and the 'Squawk Box' team to discuss the company's latest Covid-19 vaccine booster strategies against the concerning omicron variant. Bancel breaks down how many booster doses the mRNA maker will be able to produce in 2022 and lays out Moderna's latest collaboration with Carisma Therapeutics to develop an in vivo engineered CAR-M treatment for cancer.